PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportspulmonary arterial hypertension
MeSH D000081029 - pulmonary arterial hypertension
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D006976:Pulmonary hypertension
101 Companies
21 Drugs
$
Success rate
D000081029: 
Pulmonary arterial hypertension
1 Company
1 Drug
$
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
36%
16/45
Phase 2
47%
22/47
Phase 3
50%
13/26
Approved: 0Overall Success rate: 8%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Merck & Co
Sotatercept,
Ademetionine,
Tezosentan,
Aspartame,
Xenon xe 127,
Evidence
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use